These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6169479)

  • 21. Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors.
    Meyer JL; Smith LH
    Invest Urol; 1975 Jul; 13(1):36-9. PubMed ID: 166960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of some urinary stone inhibitors on membrane interaction potentials of stone crystals.
    Mandel NS; Mandel GS; Hasegawa AT
    J Urol; 1987 Sep; 138(3):557-62. PubMed ID: 2442419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Growth of calcium oxalate crystals in vitro: a simple method for measurement of the inhibitory action of human urine (author's transl)].
    Hess B; Binswanger U
    J Clin Chem Clin Biochem; 1981 May; 19(5):295-9. PubMed ID: 7264571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A study of inhibitory effect of chondroitin polysulfate on stone formation of calcium oxalate].
    Fujisawa M; Arima S; Yachiku S
    Nihon Hinyokika Gakkai Zasshi; 1992 Oct; 83(10):1647-54. PubMed ID: 1434267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of chondroitin sulfate, heparin sulfate, and citrate on Proteus mirabilis-induced struvite crystallization in vitro.
    McLean RJ; Downey J; Clapham L; Nickel JC
    J Urol; 1990 Nov; 144(5):1267-71. PubMed ID: 2122009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Separate effects of urinary chondroitin sulphate and heparan sulphate on the crystallization of urinary calcium oxalate: differences between stone formers and normal control subjects.
    Shum DK; Gohel MD
    Clin Sci (Lond); 1993 Jul; 85(1):33-9. PubMed ID: 8149691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitors of crystal growth of hydroxyapatite: a constant composition approach.
    Wilson JW; Werness PG; Smith LH
    J Urol; 1985 Dec; 134(6):1255-8. PubMed ID: 2997488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variations in the activity of urinary inhibitors in calcium oxalate urolithiasis.
    Grases F; Genestar C; March P; Conte A
    Br J Urol; 1988 Dec; 62(6):515-20. PubMed ID: 2851362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary trefoil factor 1 is a novel potent inhibitor of calcium oxalate crystal growth and aggregation.
    Thongboonkerd V; Chutipongtanate S; Semangoen T; Malasit P
    J Urol; 2008 Apr; 179(4):1615-9. PubMed ID: 18295252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors affecting the regrowth of renal stones in vitro: a contribution to the understanding of renal stone development.
    Costa-Bauzá A; Isern B; Perelló J; Sanchis P; Grases F
    Scand J Urol Nephrol; 2005; 39(3):194-9. PubMed ID: 16118089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium oxalate dihydrate formation in urine.
    Martin X; Smith LH; Werness PG
    Kidney Int; 1984 Jun; 25(6):948-52. PubMed ID: 6471675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycoprotein calcium oxalate crystal growth inhibitor in urine.
    Worcester EM; Nakagawa Y; Coe FL
    Miner Electrolyte Metab; 1987; 13(4):267-72. PubMed ID: 3306319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of glycosaminoglycans on calcium oxalate crystal aggregation.
    Shirane Y; Yamamoto A; Mizuta K; Kagawa S
    Tokushima J Exp Med; 1989 Dec; 36(3-4):81-5. PubMed ID: 2517714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of urine pretreatment on calcium oxalate crystallization inhibition potentials.
    White DJ; Christoffersen J; Herman TS; Lanzalaco AC; Nancollas GH
    J Urol; 1983 Jan; 129(1):175-9. PubMed ID: 6827679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of urinary material and glycosaminoglycans on calcium oxalate monohydrate crystal aggregation].
    Shirane Y; Yamamoto A; Mizuta K; Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1989 Jul; 80(7):1000-3. PubMed ID: 2514310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of urinary macromolecules on calcium oxalate monohydrate crystal growth.
    Lanzalaco AC; Singh RP; Smesko SA; Nancollas GH; Sufrin G; Binette M; Binette JP
    J Urol; 1988 Jan; 139(1):190-5. PubMed ID: 3336094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitors of oxalocalcic lithiasis: effects of their interactions on calcium oxalate crystallization.
    Muñoz JA; López-Mesas M; Valiente M
    Urology; 2012 Nov; 80(5):1163.e13-8. PubMed ID: 22748613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of trace metals on the inhibition of calcium oxalate crystallization.
    Muñoz JA; Valiente M
    Urol Res; 2005 Aug; 33(4):267-72. PubMed ID: 15937709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inhibitory effect of CG-120 on the formation, growth and aggregation of calcium oxalate crystals in vitro].
    Suzuki K; Tsugawa R
    Hinyokika Kiyo; 1988 Jun; 34(6):1073-6. PubMed ID: 3223452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of glycosaminoglycans on calcium oxalate crystal formation].
    Shirane Y; Hamao T; Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1990 Jul; 81(7):1065-70. PubMed ID: 2214470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.